Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Future CAGR is Anticipated for the Neurological Biomarkers Market Over the 2025–2034 Period?

The neurological biomarkers market has grown rapidly in recent years. It is forecasted to expand from $10.7 billion in 2024 to $11.96 billion in 2025, at a CAGR of 11.7%. This market’s past growth has been fueled by the increasing prevalence of neurological disorders, an aging population, the need for drug development, increased funding for neurological research, and the expansion of personalized medicine.

The neurological biomarkers market is set for rapid expansion, projected to grow to $19.96 billion by 2029 at a CAGR of 13.7%. This growth will be driven by increased demand for early detection biomarkers, advancements in biosensors and wearable devices, global health initiatives, and a shift toward patient-centric healthcare approaches. Key trends will include technological advancements in imaging, rapid progress in omics technologies, AI integration in biomarker research, real-world evidence validation, and strengthened collaboration between industry and research institutions.

Which Drivers Are Expected to Have the Greatest Impact on the neurological biomarkers Market’s Growth?

The growing prevalence of neurological diseases is expected to boost the growth of the neurological biomarker market. Neurological diseases affect the brain and nervous system, and biomarkers help in early diagnosis and treatment. The Parkinson’s Foundation reported in December 2022 that 90,000 new Parkinson’s disease diagnoses occurred in 2022, an increase from 60,000 the previous year. This rising prevalence of neurological diseases is propelling the growth of the neurological biomarker market.

Get Your Free Sample of the Global Neurological Biomarkers Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12677&type=smp

Who Are the Influential Players Fueling Innovation and Growth in the Neurological Biomarkers Market?

Major companies operating in the neurological biomarkers market include:

• Pfizer Inc._x000D_

• F. Hoffmann-La Roche AG_x000D_

• Merck & Co. Inc._x000D_

• Novartis AG_x000D_

• Thermos Fisher Scientific Inc._x000D_

What Impact Are Industry Trends Having on the Neurological Biomarkers Market’s Future Prospects?

In the neurological biomarkers market, major companies are forming partnerships to create new products and strengthen their market position. Collaborations in this market facilitate innovation and speed up the development of advanced therapies. For example, in July 2022, NeuroSense Therapeutics Ltd., an Israel-based company, partnered with NeuraLight, another Israeli company, to develop oculometric indicators for Amyotrophic Lateral Sclerosis (ALS) using AI and Machine Learning. This partnership, following NeuraLight’s $25 million Series A financing, aims to improve ALS diagnosis and boost clinical trial success rates by applying digital indicators for patient classification.

Get Instant Access to the Global Neurological Biomarkers Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Neurological Biomarkers Market?

The neurological biomarkers market covered in this report is segmented –

1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products

2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy

3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

Subsegments:

1) By Proteomics Biomarker: Protein Biomarkers, Antibody Biomarkers

2) By Genomics Biomarker: DNA Biomarkers, RNA Biomarkers

3) By Metabolomics Biomarker: Metabolite Biomarkers, Lipid Biomarkers

4) By Imaging Biomarker: MRI Biomarkers, PET Scan Biomarkers

5) By Other Products: Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers

What Regions Are Leading the Growth Trajectory of the Neurological Biomarkers Market?

North America was the largest region in the neurological biomarkers market in 2024. The regions covered in the neurological biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Characteristics That Define the Neurological Biomarkers Market?

A neurological biomarker is a substance that provides objective and quantifiable information about the presence, progression, or characteristics of a neurological disorder or condition. They are used in clinical practice during drug development.

Browse Through More Similar Reports By The Business Research Company:

Cardiac Biomarkers Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Neurology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Renal Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: